Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,573.40
(
-0.12%
)
US TECH 100
23,370.40
(
-0.64%
)
Dow Jones
46,245.76
(
0.08%
)
Brent Oil
99.31
(
2.60%
)
Bitcoin
69,907.00
(
-1.41%
)
News Focus
News Focus

Replies to post #163926 on Biotech Values

Replies to #163926 on Biotech Values
icon url

ciotera

07/12/13 10:23 AM

#163930 RE: oc631 #163926

Why wouldn't GILD run a GT2 study in Russia?

Because over half of HCV patients in Russia are GT1b, while GT2 is in single digits.